Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus.

Newby D. et al, (2022), BMJ Open Diabetes Res Care, 10

Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain health.

Gadd DA. et al, (2022), Nat Commun, 13

Validation of UK Biobank data for mental health outcomes: A pilot study using secondary care electronic health records.

Li Z. et al, (2022), Int J Med Inform, 160

Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.

Liu Q. et al, (2022), BMC Med, 20

The Relationship Between Isolated Hypertension with Brain Volumes in UK Biobank

NEWBY D., (2022), Brain and Behavior

CHRONOSIG: Digital Triage for Secondary Mental Healthcare using Natural Language Processing - rationale and protocol

Joyce DW. et al, (2021)

Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.

Xu J. et al, (2021), Biomedicines, 9

Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data.

Sommerlad A. et al, (2021), Int J Geriatr Psychiatry

Epigenome and phenome study reveals circulating markers pertinent to brain health

Gadd DA. et al, (2021)

Replication study of plasma proteins relating to Alzheimer's pathology.

Shi L. et al, (2021), Alzheimers Dement, 17, 1452 - 1464

Genome and epigenome wide studies of plasma protein biomarkers for Alzheimer′s disease implicate TBCA and TREM2 in disease risk

Hillary RF. et al, (2021)

High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank.

Sproviero W. et al, (2021), Biol Psychiatry, 89, 817 - 824

Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort

Xu J. et al, (2021)

Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice.

Martín-Sánchez A. et al, (2021), Alzheimers Res Ther, 13

ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.

Birkenbihl C. et al, (2021), J Alzheimers Dis, 79, 423 - 431

Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank.

Newby D. et al, (2021), J Alzheimers Dis, 84, 1373 - 1389

Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.

Shi L. et al, (2021), Front Aging Neurosci, 13

Urinary metabolic phenotyping for Alzheimer's disease.

Kurbatova N. et al, (2020), Sci Rep, 10

Utilization of the Signature Method to Identify the Early Onset of Sepsis From Multivariate Physiological Time Series in Critical Care Monitoring.

Morrill JH. et al, (2020), Crit Care Med, 48, e976 - e981

Load More

Include forthcoming?